Member Info for Aldebaran

Ice did you say you had done another case study if so I missed it so can you post again please. Also could you post original one again as my hard drive broken and I lost, it. Thank you

Yes so if we're building supply chains in USA it bodes well for the short registrational P2 and mass sale then no?

Manufacturing in USA to avoid tarrifs presumably

Notposting can you just chill a bit. Let's all just take it down a notch eh?

This supposed to be a public discussion board where we talk about Hemo

And avacta 🤣

Haha got you all

dya know what. actually i kind of respect that post archbishop holmes. why? because you've actually bothered to research it. ok your researching it with a prejudice so you can come here and slate it but fair is fair. you've scratched the surface.

let me give you a little steer. all those diseases you listed. doxorubicin doesnt work in them mate. it never has and never will. thats why ava6000 didnt work in them.

the point of the p1 trial was only to prove that the delivery system worked and the company put 100x more drugs in all those tunours than the blood. 100x. so the delivery system works. it delivers almost any drug to the tumour and spares healthy tissue along the way.

now, where doxorubicin does have activity is in salivary gland cancer and guess what, 91% of the people who took it responded very favourably given they had already exhausted all other treatment options and had refractory tumours.

now thats all im telling you, cos you are a bit of a *****. keep going with the deramping research because eventually the penny will drop just how exceptional avacta is. it knocks the socks off hemo in every way possible. it really does

13:37 post by Archbishop. 1 word. Brilliant 🤣

Just brilliant 👏

Talk about showing yourself up mate 🤣🤣

I have zero desire to correct and educate you. Your right mate. Absolutely 100% right. I cant believe i didnt realise earlier 😅

You know , for a long time ive thought you were an idiot and now you've confirmed. Thanks for the lols

What? No im not taking counter offers thanks. Forget it. I was being genuine and I would honor my word but whatever I won't bother.

Look its real simple, there is no clarity or visibility on anything for investors, right now its all just guesswork.

How long will TT take? How long did it take last time? Quite a while from memory. All that time cash is being burned and Vlad after going to those mega deal making conferences in DC and NYC armed with cohort 1 data walks away with nothing. Zilch. Remember you guys all saying how people would have their check books queuing up to meet vlad and congress people would all be insider dealing scrambling to buy shares urgently. None of that happened yet were supposed to believe vlad the dealmaker is going to get a deal here before the cash runs out? I dont think so.

I think he needs more data from adults and kids and when will he have that, zero idea.

I posted here after watching Vlads interview. Just because I have a different view on what was presented or should I say not presented, than you lot and dont end my post with go hemo go im attacked.

Matters not, what is important is making money. Tell you what ill make you and all you lot a deal.

I'll never post on hemo board again if HEMO gets to 1600p from here quicker than Avacta gets to 300p from current price (60p). How's that sound? You cant lose with those odds right?

But if Avacta do beat hemo, whichI guarantee they will, then you all have to write one post each about how right I was and continue to be and how you wish you listened to me more and spent some time researching Avacta rather than cheerleading here every day.

How's that sound?

Your posts are full of paranoia and hyperbole JHFH.

Mine are grounded in reality. Im short now am I? Ok your right. As always 👍

Seriously now I mean seriously. Go live your lives. Zero point posting ball axe here every day. There will be nothing material until 2027. Few pops and drops along the way but thats all and then a placing around 5p next year.

A solid chart would have all moving averages in correct order.

A series of higher highs and lower lows creating a solid foundation

Moving averages pointing upwards

Increasing momentum

Hemo chart looks like and im not saying it is but it looks like a pop and drop pump and dumps just like it has previously. Tell me im wrong? Thats what it looks like to me

SocialistB, I have no plans to leave. I dont just comment based on what the price is on any given day.

Do I think Q1... sorry but no I don't. I expected an expedited review from the safety committee given it was only 3 patients data and all 3 supposedly clean. And then expected patient recruitment to be going on in the background and company ready to dose by mid Oct.

Right now, we are already behind my estimated timelines. Ok maybe I was ambitious but what are we supposed to do in the absence of any guidance from the company? Thats sorely missing here.

Sorry to say but compare to avacta who have these things spelt out. We know next and most crucial RNS for our P1b data coming before Xmas.

We know our next drug IND completes by year end and it enters the clinic by Q1

We know breast cancer data coming by end H1 2026

We know which steps are going to inform on accelerated approval pathways

We know CLN payments have been deferred until 2027 and we knew very specifically that we needed at least £13m by end January so funding requirements all spelt out

We know there are multiple commercial options on the table and that the p1b data is what BP are waiting for

All this isnt investor guesses, it is spelt out in RNS and investor webinars - the types with Q&A i might add. Speaking of which we know that between now and year end we have another investor webinar, more R&D spotlights and a science day at least.

Am I ramping avacta, maybe a tad, but im also trying to highlight how other biotechs can and do do things. Roadmap for avacta is clear. For hemo its just a total guess and currently doesnt look like going anywhere soon. Thats all I can infer from latest update.

Might not be what you wanna here but doesnt make it less true im afraid.

I'm genuinely perplexed what y'all so excited about

2 patients per month is not 2 adults and 1 child its 1 child and 1 adult which is NOT what we all expected.

How long will next phase last? Vlad has no idea

Good signs of efficacy, ultimately Vlad confirmed we have to go through phase 2 though

How long will it be before Estonia is going? Vlad has no idea, infact we dont know if this non binding letter of intent will actually lead to anything at all

Financial position, burn rate reduced, longer run way but Vlad confirmed that HEMO need more money and and a lot of it. Vlad is TRYING to get this in non dilutive way but how?

I dont buy it.

He then starts talking about how great the chart is... I mean that was the most bizzare part of the whole interview for me. The chart is a abomination.

Your tone implys its some kind of "gotcha" moment when ive said repeatedly I believe hemo to be undervalued. What more do you want from me? You apply your own risk weighting and come up with your own figures. Personally I think HG-CT-1 is worth more than the current market cap.

Want me to put this in neon lights or what?

Now, just because the ultimate value if this does turn out to be fully proven to work, is high. It doesnt mean that in the time it takes to get to that valuation might be extremely difficult and take a long time and infact cause unnecessary high levels of dilution to investors through poor management..

Thats why applying technicals are also important.

See you at 500p chaps

Socialistb... we're supposed to just belief that Vlad has given you insider info of this magnitude and now your posting it here.

Lol

I dont believe a word of it. We're is your proof or evidence to back up the claim multiple pharma are in talks with vlad for a buyout?

Peter what don't you understand about my reply?

Ive said company is undervalued and ive demonstrated how and why I belove that to be the case.

I've said that it remains technically weak and likely to sell off though and I've given reasons for why I think that.

It can be cheap and get cheaper, its how the market works. Things stay undervalued for a long time.

Hi, ok my view is that you need to first be honest with yourselves and on the board. Engage with those who are researched and have alternative views instead of resulting to personal attacks and dismissing anything said as those it's some nefarious attempt at manipulation.

Use this bulletin board as for what it is intended. Discussion.

Second, research some other small cap biotechs, see how they're doing things, what do you like what do you dislike

Once you know, lobby Vlad for the changes you want and if it comes to it, vote him out at next chance. Even if you don't win its making a point.

Ensure you aren't all in on this one stock. No matter what.

Stop averaging down or buying more unless its on the back of fundamental news or at some kind of technical level supported by high volume. The amount of people buying in no man's land here or claiming to buy is shocking.

So there's a few genuine ideas to what I believe was a genuine question.

Believe it or not I want private investors to do well and I want hemo treatment to be a success and save many lives. Hope both those thingd happen. If we all talk with each other rather than being so tribal it would be so much better

Hemo should be 300m market cap well we may have to reduce that down now timelines are less clear but I standby the statement hemo is undervalued.

Doesn't mean it won't stay undervalued or even become more undervalued. The market can stay irrational longer than most can stay solvent.

So fundamentally undervalued yet technically extremely weak for the short term at least. Both those things can be true simultaneously. What is so difficult about that to understand with you people.

King Steve. Just to educate you on stops. If anyone has placed stops most likely they would be below recent low. This wasn't a stop hunt it is the beginning of yet another sell off capitulation event. Why do I think that? Another close below 50dma and 3rd close below 900p in short period.

Fundamentally their are zero timelines or clarity on tech transfer, on recruitment, on dosing, on funding, on Estonia on anything. Infact we still dont know if the patience are alive and if their not, how long they lived.

Last update said no detectable cancer cells by standard methods... when will we get the detailed test results? Ever, never?

This is why the market is and will sell off. But hey, this is the way JHFH is advising Vlad, so at least traders cant make any money!

Wake up, the lot of you. Wake the fk up

I back my comments with evidence though King Steve. Technical Analysis, fundamental DCF calculations, company RNS's and information learnt about alternative treatments etc..

Where is your evidence that stops were taken out and price will rally up again tomorrow. You want to talk, let's talk. Shoot, im listening. We all are

Pumpkin that is exactly right, its ok these lot saying the low share count is great as you get rapid moves upwards on positive news but yes correct on negative news, the likes of which we just had despite how much these try to spin it, the share price can move down rapidly.

Another close below 900p and the 50dma is not a good sign.